Ann: HOA to establish Singapore Plasma Fractionat, page-4

re: Ann: HOA to establish Singapore Plasma Fr...
Clearly something went completely skew with the Singapore based potential financiers having fallen out badly. This is a real pity considering that the Singapore government departments were giving excellent support. Has the Singapore govt 'loan' of S$1M also been scuttled? The fact that the fractionation facility is still to be located in Sing must mean something. Performing the clinical trials in a country of first world status is of great value in establishing new markets.

In the present new scenario NSP loses a significant part of its IP (to be jointly held with the new partner).

The underlying thinking behind the scheme may well have been: We need some major funding to make real progress in SE Asia. The shareholders are not going to brook a further series of incremental capital raisings when the past history of real achievement of goals has been dismal. Since the only tradable asset that NSP has is its IP why don't we convert part of that into a sizable dollop of funds and set up the facility once and for all with some speed. The injection of $20 M cash into NSP should also allow immediate progress on the other arms of the company.

The PrIME technology has never been used to a significant extent. It can be reasoned that after decades of sitting dormant this is a once off opportunity to put it into the market. The technology is magnificent in that it does have the capacity to make silk purses from a sow's ear (separating 'unprocessable' plasma).

The new Middle East markets are mentioned but the Philippines project with United Labs is ignored. Meaningful? I hope that this venture does not become another wasting exercise in wheeling and dealing.

Juke